These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 9920038)
1. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038 [TBL] [Abstract][Full Text] [Related]
2. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells. Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536 [TBL] [Abstract][Full Text] [Related]
3. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768 [TBL] [Abstract][Full Text] [Related]
4. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi. Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980 [TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: lack of T cell abnormalities in mice vaccinated with live trypomastigotes. Paiva CN; Castelo-Branco MT; Rocha JA; Lannes-Vieira J; Gattass CR Parasitol Res; 1999 Dec; 85(12):1012-7. PubMed ID: 10599925 [TBL] [Abstract][Full Text] [Related]
6. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607 [TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. Nickell SP; Sharma D Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388 [TBL] [Abstract][Full Text] [Related]
8. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function. Miller MJ; Wrightsman RA; Stryker GA; Manning JE J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953 [TBL] [Abstract][Full Text] [Related]
9. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. Wizel B; Nunes M; Tarleton RL J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413 [TBL] [Abstract][Full Text] [Related]
10. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction? Basso B; Marini V Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810 [TBL] [Abstract][Full Text] [Related]
11. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. Khan IA; Casciotti L J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393 [TBL] [Abstract][Full Text] [Related]
12. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. Tarleton RL J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903 [TBL] [Abstract][Full Text] [Related]
13. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels. Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095 [TBL] [Abstract][Full Text] [Related]
14. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297 [TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response. Miller MJ; Wrightsman RA; Manning JE Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765 [TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine. Miyahira Y Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174 [TBL] [Abstract][Full Text] [Related]
17. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice. Fierer J; Waters C; Walls L J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371 [TBL] [Abstract][Full Text] [Related]
18. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070 [TBL] [Abstract][Full Text] [Related]
19. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. Nickell SP; Stryker GA; Arevalo C J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987 [TBL] [Abstract][Full Text] [Related]
20. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease. Lopes MF; da Veiga VF; Santos AR; Fonseca ME; DosReis GA J Immunol; 1995 Jan; 154(2):744-52. PubMed ID: 7814881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]